IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Essex Woodlands Management, Inc.

Q1 2014 Holdings

Filed 2014-05-15 | 11 holdings | $392.8K | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Revance Therapeutics Inc(RVNCEUR)COM761330109$144.6K4,592,04736.8%
Horizon Pharma IncCOM44047T109$85.1K5,815,94021.7%
Abiomed Inc(ABMDEUR)COM003654100$82.0K3,150,00020.9%
Endologix IncCOM29266S106$51.6K1,165,42813.1%
Acura Pharmaceuticals IncCOM NEW00509L703$14.3K10,294,8863.6%
Ziopharm Oncology IncCOM98973P101$11.8K2,764,9083.0%
Medicinova Inc(MNOV)COM NEW58468P206$2.4K1,170,3700.6%
Curis IncCOM231269101$659233,7970.2%
China Cord Blood CorpSHSG21107100$34786,7630.1%
Echo Therapeutics IncCOM NEW27876L206$3712,3190.0%
Palatin Technologies IncCOM PAR $ .01696077403$2923,9280.0%